Institutions / Twin Securities, Inc.
Twin Securities, Inc.
CIK 1351351 · Institution · as of Mar 31, 2026
Portfolio value
$202.31M
Positions
16
As of
Mar 31, 2026
Portfolio trend
Portfolio value
$202.31M-22.5%Positions
16+0.0%Top holdings
Mar 31, 2026
| Company | Value | % of portfolio |
|---|---|---|
| Electronic Arts Inc. | $91.12M | 45.0% |
| Warner Bros. Discovery, Inc. | $35.70M | 17.6% |
| Clearwater Analytics Holdings, Inc. | $27.53M | 13.6% |
| Hologic Inc | $13.53M | 6.7% |
| Kenvue Inc. | $8.28M | 4.1% |
| Arcellx, Inc. | $6.20M | 3.1% |
| Terns Pharmaceuticals, Inc. | $6.11M | 3.0% |
| Apellis Pharmaceuticals, Inc. | $5.13M | 2.5% |
| Revolution Medicines, Inc. | $3.75M | 1.9% |
| Onestream, Inc. | $1.45M | 0.7% |
| Take Two Interactive Software Inc | $1.28M | 0.6% |
| Day One Biopharmaceuticals, Inc. | $678.1K | 0.3% |
| Atrium Therapeutics, Inc. | $667.3K | 0.3% |
| TIC Solutions, Inc. | $508.9K | 0.3% |
| Manchester Utd PLC New | $251.0K | 0.1% |
| Surgery Partners, Inc. | $119.5K | 0.1% |
Activity
Mar 31, 2026View full history →
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q1 2026 as of | Exit | M2682V108 | $-59.39M | -133K -100.00% | — | high |
| Q1 2026 as of | Exit | Exact Sciences Corp. | $-49.11M | -484K -100.00% | — | medium |
| Q1 2026 as of | Add | Electronic Arts Inc. | $42.22M | +207K +86.36% | 446,948 45.04% of portfolio | medium |
| Q1 2026 as of | Add | Clearwater Analytics Holdings, Inc. | $26.36M | +1.1M +2260.57% | 1,164,090 13.61% of portfolio | medium |
| Q1 2026 as of | Exit | Avidity Biosciences, Inc. | $-26.34M | -365K -100.00% | — | medium |
| Q1 2026 as of | Exit | Confluent, Inc. | $-15.29M | -505K -100.00% | — | medium |
| Q1 2026 as of | Exit | Norfolk Southern Corp | $-7.28M | -25K -100.00% | — | medium |
| Q1 2026 as of | Add | Hologic Inc | $7.14M | +95K +111.84% | 179,036 6.69% of portfolio | medium |
| Q1 2026 as of | New | Arcellx, Inc. | $6.20M | +54K | 53,982 3.06% of portfolio | medium |
| Q1 2026 as of | New | Terns Pharmaceuticals, Inc. | $6.11M | +116K | 115,958 3.02% of portfolio | medium |